Gene Query: MRPS18A

Dataset Description Geneva Score
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 28.32
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 23.88
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 22.14
Paxillin regulates genomic networks in prostate cancer [C4-2] 20.82
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 19.67
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 19.67
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 16.08
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 16.03
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 14.39
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 14.38
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 13.53
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 13.49
RNAseq Analysis in glioblastoma cells treated with Mepazine 12.11
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 11.93
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 11.58
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 11.58
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 11.48
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 11.44
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 11.27
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 11.27
EWSR1 influences alternative splicing through direct and indirect mechanisms 10.51
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 10.43
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 10.43
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 10.4
DART-seq: an antibody-free method for global m6A detection 10.02
Human Treg IL-12 stimulation 9.58
R430: A potent inbibitor of DNA and RNA viruses 9.31
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 9.3
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 8.99
Comprehensive comparative analysis of 5’ end RNA sequencing methods 8.81
Transcriptome analysis of SKI knock-out in HL60 cells 8.42
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 8.42
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 8.4
Genome wide expression change by RNF168 knocking down in MCF-7 cells 8.33
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 8.1
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 7.8
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 7.75
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 7.66
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 7.66
Expression by CD133+ cells isolated from the adult human exocrine pancreas 7.49
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 7.49
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 7.45
Transcriptional landscape changes during human embryonic stem cell derivation 7.42
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 7.42
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 7.38
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 7.31
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 7.28
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 7.18
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 7.16
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 7.09
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 7.02
Generating Patterned Kidney Organoids for Studying Development and Diseases 7.01
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 7.01
Differential gene expression of human melanoma cells [RNA-seq] 7.01
SUV420H2 knockdown in PANC-1 6.82
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 6.79
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 6.71
Role for citron kinase in prostate cancer growth 6.68
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 6.55
Integrin signaling regulates YAP/TAZ to control skin homeostasis 6.4
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 6.36
The evolution of N6-methyladenosine in primates 6.35
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 6.32
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 6.32
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 6.31
Impact of dieldrin on transcription in Jurkat T cells 6.31
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 6.28
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 6.28
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 6.24
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 6.24
Identification of transcription start sites for human A549 cell line using ReCappable-seq 6.23
Expression charcaterization of an internal protocol developed to differentiate RPE cells 6.13
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 6.13
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 6.03
single cell RNA-seq from GM12878 (ENCSR673UIY) 5.98
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 5.92
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 5.84
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 5.83
Genome wide expression change by RNF168 knocking down in NEC cells 5.75
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 5.55
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 5.53
Global analysis of enhancer targets: Mosaic-seq 5.49
Accurate annotation of human protein-coding small open reading frames 5.49
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 5.49
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 5.44
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 5.42
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 5.42
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 5.32
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 5.26
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 5.26
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 5.25
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 5.24
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 5.24
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 5.24
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 5.22
Total RNA sequencing of WT intestinal orgaonids. 5.2
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 5.12
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 5.1
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 5.06
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 5.01
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 5.0
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 5.0
Trans-differentiation of human adult peripheral blood T cells into neurons 4.98
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 4.89
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 4.89
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 4.86
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 4.84
PRDM1 inhibits proliferation of human colon cancer organoids 4.83
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 4.83
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 4.74
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 4.74
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 4.74
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 4.74
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 4.74
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 4.71
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 4.69
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 4.69
Illumina Total RNA-seq in HeLa 4.68
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 4.66
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 4.63
A Unique Epigenomic Landscape Defines Human Erythropoiesis 4.63
A transcriptome-wide divergence in protein translation scales with LIN28B expression 4.6
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 4.59
Iron response of HepG2 cells 4.52
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 4.5
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 4.46
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 4.4
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 4.39
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 4.38
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 4.36
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 4.33
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 4.31
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 4.31
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 4.31
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 4.3
Effect of disulfiram treatment on pediatric high grade glioma 4.28
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 4.25
snRNAs as regulators of alternative splicing 4.23
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 4.23
Crizotinib v. DMSO in SW480 cells 4.22
Survival of pancreatic cancer cells lacking KRAS function 4.2
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 4.19
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 4.18
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 4.16
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 4.16
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 4.14
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 4.14
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 4.06
Genes significantly down or Up-regulated upon RNF219 knockdown 4.03
Spliceosomal disruption of the non-canonical BAF complex in cancer 4.02
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 4.02
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 4.02
The comparison of high-throughput single-cell RNA-seq methods 4.0
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 3.98
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 3.96
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 3.94
Differetially expressed genes after hTR overexpression in U2OS cells 3.92
ETV7 and interferon response 3.92
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 3.92
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 3.89
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 3.88
Novel Targeting of Transcription and Metabolism in Glioblastoma 3.87
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 3.85
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 3.83
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 3.83
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 3.81
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 3.81
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 3.8
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 3.8
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 3.79
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 3.78
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 3.78
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 3.77
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 3.76
RNA-seq analysis of control and Myc-induced U2OS cells 3.75
Cellular response to hepatitis E virus (HEV) infection 3.73
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 3.73
Single-cell analysis of adult human ovary using 10X genomics 3.71
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 3.7
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 3.7
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 3.7
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 3.69
A novel target of EZH1/2 for treatment of mantle cell lymphoma 3.68
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 3.68
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 3.68
Identification of HOXB13 target genes responsive to BET inhibitors 3.65
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 3.62
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 3.62
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 3.61
RNA editing in nascent RNA affects pre-mRNA splicing 3.61
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 3.6
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 3.59
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 3.59
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 3.59
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 3.57
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 3.57
Identification of renal resident macrophages across species [C1] 3.57
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 3.55
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 3.51
NRDE2 negatively regulates nuclear exosome functions 3.51
The transcriptome effect of overexpressing EZH2 in MCF7 3.5
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 3.49
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 3.48
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 3.45
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 3.41
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 3.41
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 3.41
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 3.41
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 3.35
CROP-Seq in Primary Human T Cells 3.34
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 3.32
Dtx3L and Androgen Signaling in Prostate Cancer 3.31
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 3.3
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 3.29
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 3.28
RNA-Seq analysis of human colorectal cancer with liver metastasis 3.24
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 3.23
High-throughput sequencing of pluripotent cells 3.23
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 3.22
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 3.21
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 3.21
RNAseq Study in CC-671 Treated Cal-51 Cells 3.17
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 3.16
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 3.16
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 3.15
RNA-seq of naive and primed ES cells 3.13
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 3.12
A single cell reference map for human blood and tissue T cell activation 3.11
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 3.1
Seletive inhibition of CDK9 in DLBCL cell lines 3.1
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 3.07
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 3.07
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 3.07
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 3.07
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 3.06
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 3.04
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 3.04
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 2.97
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 2.96
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 2.92
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 2.92
Stem and effector CD8 T-cells from human cancers 2.91
RNAseq analysis of ESRP regulated splicing events in prostate cancer 2.89
The effect of insulin on mRNA transcription of human pluripotent stem cells 2.87
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 2.87
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 2.86
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 2.84
scRNASeq analysis of cycling cardiomyocytes 2.83
Oncogenic MYC induces a dependency on the spliceosome in human cancer 2.81
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 2.79
CD73 knockdown effect in pancreatic cancer cell lines 2.78
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 2.76
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 2.76
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 2.75
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 2.69
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 2.68
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 2.68
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 2.66
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 2.65
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 2.64
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 2.64
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 2.64
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 2.63
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 2.63
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 2.6
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 2.59
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 2.54
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 2.54
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 2.51
Transcriptome analysis of CNS leukemia 2.51
Ribosome profiling upon inhibition of eIF4A 2.47
Transcriptome landscape of HeLa response upon triamcinolone acetonide 2.47
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 2.46
Unique features and clinical importance of acute alloreactive immune responses 2.44
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 2.44
Transcriptional responses of melanoma cells to BRAF inhibition 2.41
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 2.39
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 2.38
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 2.37
NR2F2 study 2.37
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 2.36
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 2.36
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 2.36
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 2.35
miRNAs affected by antagomiR-17 treatment 2.34
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 2.33
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 2.28
ARS2 is a general suppressor of pervasive transcription [RNAseq] 2.26
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 2.24
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 2.23
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 2.22
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 2.22
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 2.22
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 2.21
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 2.19
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 2.19
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 2.16
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 2.14
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 2.14
TT-Seq captures the human transient transcriptome 2.13
Gene expression signatures of innate lymphoid cells from human blood 2.13
The cohesin complex prevents Myc-induced replication stress 2.12
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 2.1
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 2.1
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 2.1
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 2.05
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 2.04
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 2.03
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 1.98
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 1.98
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 1.97
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 1.91
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 1.9
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 1.9
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 1.87
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 1.87
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 1.87
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 1.87
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.86
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 1.85
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 1.85
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 1.85
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 1.81
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.81
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 1.8
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 1.75
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 1.75
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 1.75
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 1.75
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 1.73
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 1.72
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 1.68
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 1.64
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 1.64
Identification of renal resident macrophages across species 1.64
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.63
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 1.62
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 1.62
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 1.61
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 1.58
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 1.55
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 1.53
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 1.5
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 1.48
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 1.46
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 1.46
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 1.44
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.43
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 1.43
Real-time observation of light-controlled transcription in living cells 1.42
Targeting MTHFD2 in Acute Myeloid Leukemia 1.4
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 1.4
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 1.39
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 1.38
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 1.37
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 1.35
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 1.35
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 1.35
Functional significance of the HIV-1 Tat signature amino acid residues 1.34
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 1.31
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 1.31
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 1.31
Transcriptome sequencing of K-562 cells 1.28
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 1.25
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 1.25
RNAseq of cell lines with knocked in ESR1 mutations 1.24
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 1.24
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 1.23
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 1.21
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 1.21
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 1.2
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 1.19
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 1.17
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 1.15
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 1.15
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 1.13
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.12
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 1.11
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.1
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 1.1
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 1.08
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 1.07
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 1.06
Human Treg NaCl stimulation 1.06
mRNA recovered upon RNF219 IP. [RNA-IP] 1.03
H1609088 Human RNA-Sequencing 1.03
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 1.02
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 1.02
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 1.0
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.0
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 0.99
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 0.96
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 0.91
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.9
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.9
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 0.89
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.89
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.89
Effect of drugs on transcriptomic profiles 0.87
Impact on erythroid progenitor type on erythroid differntiation 0.87
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.84
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.84
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 0.83
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 0.83
Energy Metabolism during Anchorage-Independence 0.82
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.82
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.82
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.82
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 0.82
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.81
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 0.79
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.78
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 0.78
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 0.77
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 0.76
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.74
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.74
RNA-seq of naive and primed ES cells (NHSM) 0.74
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 0.73
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 0.71
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 0.71
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 0.71
Effect of ILF3 on translation during homeostasis and the antiviral response 0.71
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 0.7
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.7
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.7
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 0.69
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 0.69
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 0.68
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.67
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 0.65
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 0.65
Molecular Criteria for Defining the Naive Human Pluripotent State 0.65
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.64
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.64
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 0.63
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 0.63
Tracing Enhancer Networks using Epigenetic Traits (TENET) 0.62
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 0.61
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 0.59
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.57
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.57
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 0.55
Discovering human diabetes-risk gene function with genetics and physiological assays 0.55
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.54
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.52
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 0.52
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 0.5
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 0.49
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.47
Global transcriptome analysis of WT versus HEB-/- hESCs 0.46
KSDM1b Role in Ewing Sarcoma 0.45
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.44
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.43
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.41
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 0.39
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.37
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.37
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 0.36
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.36
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.36
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.36
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 0.36
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 0.35
An optimization system for isolating and sequencing of single human colon cancer cells 0.34
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 0.33
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.33
RNA seq with AML (NB4) cells upon FTO inhibition 0.33
RNA-Seq of PRMT1 overexpression ECA109 cells 0.3
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.27
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.27
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.27
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 0.27
FBXW7 modulates stress response by post-translational modification of HSF1 0.27
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.25
p53 activity results in DNA replication fork processivity 0.24
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.23
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 0.21
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.19
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.18
Proteomics identifies a marker signature of MAPKi resistance in melanoma 0.18
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.17
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.16
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 0.14
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 0.14
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 0.14
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.14
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 0.13
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 0.12
Determining mRNA half-lives on a transcriptome-wide scale 0.1
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 0.1
Human Treg IFNg/IL-10 subpopulations 0.1
Gene expression changes due to PARP knockdown in human cells 0.09
Function and hormonal regulation of GATA3 in human first trimester placentation 0.09
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 0.07
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.05
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.05
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 0.04
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.02
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation